MedPath

Secretaría de Salud

🇲🇽Mexico
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

27

Active:0
Completed:10

Trial Phases

4 Phases

Phase 2:2
Phase 3:1
Phase 4:6
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (18 trials with phase data)• Click on a phase to view related trials

Not Applicable
9 (50.0%)
Phase 4
6 (33.3%)
Phase 2
2 (11.1%)
Phase 3
1 (5.6%)

Diagnostic Performance of Controlling Nutritional Status as a Nutritional Screening Tool in Patients With Inflammatory Bowel Disease

Recruiting
Conditions
Inflammatory Bowel Disease 5
First Posted Date
2024-10-18
Last Posted Date
2024-10-18
Lead Sponsor
Hospital General de Mexico
Target Recruit Count
60
Registration Number
NCT06648551
Locations
🇲🇽

Nallely Hernandez Bueno, Mexico City, Cuauhtemoc, Mexico

Effect of Clinical and Biochemical Variables Over Morbidity and Mortality in Alcohol Withdrawal Syndrome Patients

Recruiting
Conditions
Alcohol Withdrawal Syndrome
First Posted Date
2024-09-10
Last Posted Date
2024-09-10
Lead Sponsor
Hospital General de Mexico
Target Recruit Count
195
Registration Number
NCT06589973
Locations
🇲🇽

Hospital General de Cuautitlan "General José Vicente Villada", Mexico City, Mexico

Two Schemes Response in Multiple Myeloma

Recruiting
Conditions
Response, Acute Phase
Survivorship
Interventions
First Posted Date
2024-02-28
Last Posted Date
2024-10-02
Lead Sponsor
Hospital General de Mexico
Target Recruit Count
83
Registration Number
NCT06284395
Locations
🇲🇽

Hospital General de Mexico Dr. Eduardo Liceaga, Mexico City, Cdmx, Mexico

Effectiveness of a Psychological Intervention on Mental Health and Sleep.

Not Applicable
Conditions
Life Quality
Anxiety
Sleep Quality
Insomnia Chronic
Depression
First Posted Date
2023-07-19
Last Posted Date
2023-07-19
Lead Sponsor
Hospital General de Mexico
Target Recruit Count
36
Registration Number
NCT05951803
Locations
🇲🇽

Horacio Balam Álvarez García, Mexico City, Mexico

Effect of Metformin on ABCB1 and AMPK Expression in Adolescents With Newly Diagnosed Acute Lymphoblastic Leukemia

Not Applicable
Conditions
Acute Lymphoblastic Leukemia
Interventions
First Posted Date
2022-04-14
Last Posted Date
2022-04-14
Lead Sponsor
Hospital General de Mexico
Target Recruit Count
20
Registration Number
NCT05326984
Locations
🇲🇽

Hospital General de México, Mexico City, Mexico

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.